Rx Drug Marketing Ripe For New Round Of Hearings, Penn. Prosecutor Says

Pharmaceutical marketing practices have become dubious enough to warrant a new round of congressional hearings on the topic, Philadelphia Assistant U.S. Attorney James Sheehan told a Food & Drug Law Institute teleconference on pharmaceutical fraud May 24.